Electrophysiologic evidence for desensitization of α2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration

Neuropsychopharmacology

Volumn 10, Issue 1, 1994, Pages 41-51

  Mongeau, Raymond ^a   Montigny, Claude De ^a   Blier, Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antidepressant drugs; Monoamine oxidase inhibitors; Norepinephrine reuptake inhibitors; Serotonin reuptake inhibitors; 2 Adrenergic autoreceptors; 2 Adrenergic heteroreceptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BEFLOXATONE; CLONIDINE; MONOAMINE OXIDASE INHIBITOR; NISOXETINE; NORADRENALIN; OXIDOPAMINE; PAROXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; SYNAPSE;

ANIMAL; CLONIDINE; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; PRESYNAPTIC TERMINALS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SUPPORT, NON-U.S. GOV'T; SYNAPTIC TRANSMISSION;

EID: 0028328482     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.1994.6     Document Type: Article

References (46)

1. Bel N, Artigas F (1992): Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Eur J Pharmacol 229: 101-103
2. Blier P, de Montigny C (1983): Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3:1270-1278.
3. Blier P, de Montigny C (1985): Short-term lithium administration enhances serotonergic neurotransmission: Electrophysiological evidence in the rat CNS. Eur J Pharmacal 113:69-77
4. Blier P, Chaput Y, de Montigny C (1988): Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: An electrophysiological study in the rat brain. Naunyn- Schmiedebergs Arch Pharmacol 337:246-254
5. Blier P, de Montigny C, Chaput Y (1990): A role for the serotonin system in the mechanism of action of antidepressant treatments: Preclinical evidence. J Clin Psychiatry 51 (Suppl): 14-20.
6. Blier P, Bouchard C (1992): Enhancement of serotonin release in the guinea pig hypothalamus following long-term treatment with antidepressant drugs. Clin Neurophar- macol 13 (Suppl 1): 66B
7. 2- adrenergic receptors: A target for antidepressant pharmacotherapy? Intematl Acad Biomed Drug Res (In press)
8. Chaput Y, de Montigny C, Blier P (1986): Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedebergs Arch Pharmacol 333:342-348
9. Chaput Y, de Montigny C (1988): Effects of the 5-hydroxy- tryptamine receptor antagonist, BMY 7378, on 5-hydroxy- tryptamine neurotransmission: Electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 246:359-370
10. Crews FT, Smith CB (1978): Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science 202:322-324
11. Cohen Ebstein RP, Daly JW, Murphy DL (1982): Chronic effects of a monoamine oxidase inhibiting antidepressant: Decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3':5'-monophosphate systems in rat brain. J Neurosci 2:1588-1595
12. Curet O, Damoiseau G, Aubin N (1992a): Biochemical profile of befloxatone, a new reversible MAO-A inhibitor. Clin Neuropharmacol 15 (Suppl 1):424b
13. Curet O, de Montigny C, Blier P (1992b): Effect of desipra- mine and amphetamine on noradrenergic neurotransmission: Electrophysiological studies in the rat brain. Eur J Pharmacol 221:59-70
14. de Montigny C, Wang RY, Reader TA, Aghajanian GK (1980): Monoaminergic denervation of the rat hippocampus: Microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res 200:363-376
15. 2-adrenoceptor binding in elderly depressed patients. Am J Psychiatry 142:1489-1490
16. 3H]5- hydroxytryptamine release: Effects of antidepressant drugs. J Neurochem 46:218-223
17. Feuerstein TJ, Mutschler A, Lupp A, van Velthoven V, Schlicker E, Gothert M (1993): Endogenous noradrenaline activates α2-adrenoceptors on serotonergic nerve endings in human and rat neocortex. J Neurochem 61:474-480
18. Finberg JPM, Tal A (1985): Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats. Br J Pharmacol 84:609-617
19. 3H]-serotonin release from slices of rat hippocampus. Eur J Pharmacol 63:179-182
20. 3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol 81:97-106
21. Fuller RW, Snoddy HD, Perry KW (1979): Nisoxetine an-tagonism of norepinephrine depletion in brain and heart after alpha-methyl-m-tyrosine an-tagonism. Neuropharmacology 18:767-770
22. 3H]hydroxytryptamine in slices of the human neocortex. J Neurochem 59:1293-1301
23. Garcia-Sevilla JA, Guimon J, Garcia-Vallejo, Fuster MJ (1986): Biochemical and functional evidence of supersensitive platelet alpha-2 adrenoceptor in major affective disorder. Arch Gen Psychiatry 43:51-57
24. 3H (-) adrenaline to platelets of depressed patients with melancholia: Effect of longterm clomipramine treatment. Acta Psychiatr Scand 75:150-157
25. Gothert M, Huth H (1980): Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedebergs Arch Pharmacol 313:21-26
26. Gothert M, Huth H, Schlicker E (1981): Characterization of the receptor subtype involved in alpha-adrenoceptor- mediated modulation of serotonin release from rat brain cortex slices. Naunyn-Schmiedebergs Arch Pharmacol 317:199-203
27. Groß G, Hante K, Gothert M (1987): Effect of antidepressant and neuroleptic drugs on the electrically evoked release of serotonin from rat cerebral cortex. Psychopharmacology 91:175-181
28. Kandel ER, Spencer WA (1961): Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 24:243-259
29. Lacroix D, Blier P, Curet O, de Montigny (1991): Effects of long-term desipramine administration of adrenoceptors and norepinephrine reuptake: Electrophysiological studies in the rat brain. J Pharmacol Exp Ther 257:1081-1090
30. L'Heureux R, Dennis T, Curet O, Scatton B (1986): Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: Effects of drugs affecting noradrenergic transmission. J Neurochem 46:1794-1801
31. Macher JP, Schel JP, Serre C, von Frenckell R, Huck JC, Dema- rez JP (1989): Double-blind placebo-controlled study of minalcipran in hospitalized patients with major depressive disorders. Neuropsychobiology 22:77-82
32. 2-adreno- ceptors located on serotonergic nerve terminals. Naunyn- Schmiedebergs Arch Pharmacol 320:272-274
33. McMillen BA, Warnack W, German DC, Shore PA (1980): Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. Eur J Pharmacol 61:239-246
34. 2-adrenergic heteroreceptors of 5-hy- droxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedebergs Arch Pharmacol 347:266-272
35. Palfreyman MG, Mir AK, Kubina M, Middlemiss DN, Richards M, Tricklebank MD, Fozard JR (1986): Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase. Eur J Pharmacol 130:73-89
36. Piletz JE, Halaris A, Saran A, Marler M (1991): Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients. Arch Gen Psychiatry 48:813-820
37. 3H-serotonin release in the cerebral cortex. Naunyn-Schmiedebergs Arch Pharmacal 320:38-44
38. 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment. Naunyn- Schmiedebergs Arch Pharmacol 318:173-180
39. Spyraky C, Fibiger HC (1980): Functional evidence for subsensitivity of noradrenergic a2-receptors after chronic desipramine treatment. Life Sci 47:1863-1867
40. Starke K, Montel H (1973): Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12: 1073-1080
41. Svensson TH, Usdin T (1978): Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: a-Receptor mediation. Science 202:1089-1091
42. 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression. Biol Psychiatry 26:52-60
43. Thomas DR, Nelson DR, Johnson AM (1987): Biochemical effects of the antidepressant paroxetine, a specific 5-hy- droxytryptamine uptake inhibitor. Psychopharmacology 93:193-200
44. von Frenckell R, Ansseau M, Serre C, Sutet P (1990): Pooling two controlled comparisons of milnacipran (F2207) and amitriptiline in endogenous inpatients. Inti Clin Psy- chopharmacol 5:49-56
45. Willner P(1985): Depression: A Psychobiological Synthesis. NY, Wiley.
46. Yocca FD, Hyslop DK, Smith DW, Maayani S (1987): BMY 7378, a buspirone analog with high affinity, selectivity, and low intrinsic activity at the 5-HTia receptor in rat and guinea pig hippocampus membranes. Eur J Pharmacal 137:293-294